
-
AI video becomes more convincing, rattling creative industry
-
Trump says new tariff deadline 'not 100 percent firm'
-
Trump hosts Netanyahu in push for Gaza deal
-
Alpha males are rare among our fellow primates: scientists
-
At least 10 dead in Kenya during protests after heavy police deployment
-
Alcaraz, Sabalenka headline action in Wimbledon quarter-finals
-
Trump unveils first wave of steeper US tariffs, extends deadline
-
Knicks hire two-time NBA Coach of the Year Brown to guide club
-
Medical groups sue US health secretary over Covid-19 vaccine change
-
Now 48, man becomes 140th 'stolen grandchild' tracked in Argentina
-
Sinner wins Wimbledon reprieve after Dimitrov injury heartbreak, Djokovic survives
-
Trump unveils first wave of steeper US tariffs in push for deals
-
Swiss MLS goalie Frei resting at home after on-field collision
-
Relentless Spain reach Euro 2025 quarters after thumping Belgium
-
US stocks retreat from records on Trump tariff deluge
-
MLB Nationals name Cairo interim manager after shake-up
-
Sinner into Wimbledon quarter-finals after injury heartbreak for Dimitrov
-
Pacers guard Haliburton will miss entire '25-26 NBA season
-
Texas floods: How geography, climate and policy failures collided
-
Sinner into Wimbledon quarters after injured Dimitrov retires
-
UN General Assembly condemns 'systematic oppression' of women in Afghanistan
-
Epstein died by suicide, did not have 'client list': govt memo
-
Trump, Brazil's Lula clash over politically charged coup trial
-
Trump to meet Netanyahu in push for Gaza deal
-
Swiatek into Wimbledon quarter-finals
-
High-speed fall forces Philipsen out of Tour de France
-
Trump says to slap allies Japan, South Korea with 25% tariffs
-
Maresca shrugs off heat concerns as Chelsea face 'ugly duckling' Fluminense
-
Youth camp confirms 27 dead as Texas flood toll passes 90
-
US revoking 'terrorist' designation for Syria's HTS
-
Trump threatens allies Japan, South Korea with 25% tariffs
-
Relentless Spain thump Belgium to close in on Euro 2025 quarters
-
Wimbledon changes line-calling system after embarrassing blunder
-
France backs returning colonial-era 'talking drum' to I.Coast
-
King hails 'spirit of unity' as Britain remembers 7/7 attacks
-
US measles epidemic its worst of 21st century
-
Djokovic survives scare to reach Wimbledon quarters, Sinner in action
-
Looted art: the battle for looted treasures
-
Trump slaps allies Japan, South Korea with 25% tariffs
-
Belgian Merlier wins crash-marred Tour de France dash to Dunkirk
-
Celebs light up Schiaparelli to open Paris Haute Couture Week
-
Youth camp confirms 27 dead as Texas flood toll nears 90
-
Respect for Lara stops Mulder short of world Test record
-
Mexico president slams xenophobia after anti-gentrification protest
-
Djokovic stays on track for Wimbledon glory under Federer gaze
-
Belgian Merlier wins crash-marred Tour de France stage
-
Djokovic battles back against De Minaur to stay on track for Wimbledon glory
-
Israel, Hamas hold indirect talks ahead of Netanyahu-Trump meet
-
Trump steps up pressure for deals as US tariff deadline nears
-
Iran president says Israel attempted to assassinate him

Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
M.Fischer--AMWN